Scholars@Duke

• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Kotha NV, Kumar A, Qiao EM, Qian AS, Voora RS, Nalawade V, et al. Association of Health-Care System and Survival in African American and Non-Hispanic White Patients With Bladder Cancer. Journal of the National Cancer Institute. 2022 Apr;114(4):600–8.
       Full Text
    • Qiao EM, Lynch JA, Lee KM, Kotha NV, Nalawade V, Voora RS, et al. Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer. Journal of the National Cancer Institute. 2022 Apr;114(4):592–9.
       Full Text
    • Courtney PT, Deka R, Kotha NV, Cherry DR, Salans MA, Nelson TJ, et al. Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance. Journal of the National Comprehensive Cancer Network : Jnccn. 2022 Feb;20(2):151–9.
       Full Text
    • Qian AS, Schiaffino MK, Nalawade V, Aziz L, Pacheco FV, Nguyen B, et al. Disparities in telemedicine during COVID-19. Cancer Medicine. 2022 Feb;11(4):1192–201.
       Full Text
    • Salans M, Riviere P, Vitzthum LK, Nalawade V, Murphy JD. Temporal Trends and Predictors of Opioid Use Among Older Patients With Cancer. American Journal of Clinical Oncology. 2022 Feb;45(2):74–80.
       Full Text
    • Vitzthum LK, Nalawade V, Riviere P, Marar M, Furnish T, Lin LA, et al. Impacts of an Opioid Safety Initiative on United States Veterans Undergoing Cancer Treatment. Journal of the National Cancer Institute. 2022 Jan 25;
       Full Text
    • Javier-DesLoges J, Meagher M, Soliman S, Yuan J, Hakimi K, Ghali F, et al. Disparities in Telemedicine Utilization for Urology Patients During the COVID-19 Pandemic. Urology. 2022 Jan;
       Full Text
    • Schiaffino MK, Murphy JD, Nalawade V, Nguyen P, Shakya H. Association of Physician Referrals with Timely Cancer Care Using Tumor Registry and Claims Data. Health Equity. 2022 Jan;6(1):106–15.
       Full Text
    • Zhou B, Kwan B, Desai MJ, Nalawade V, Ruddy KJ, Nathan PC, et al. Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors. Fertility and Sterility. 2022 Jan 1;
       Full Text
    • Courtney PT, Deka R, Kotha NV, Cherry DR, Salans MA, Nelson TJ, et al. Active surveillance for intermediate-risk prostate cancer in African American and non-Hispanic White men. Cancer. 2021 Dec;127(23):4403–12.
       Full Text
    • Qian AS, Qiao EM, Nalawade V, Voora RS, Kotha NV, Dameff C, et al. Impact of underlying malignancy on emergency department utilization and outcomes. Cancer Medicine. 2021 Dec;10(24):9129–38.
       Full Text
    • Marar M, Bryant AK, Nalawade V, Das M, Jr BWL, Diehn M, et al. Impact of Facility Treatment Volume on Stereotactic Ablative Radiotherapy (SABR) Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology, Biology, Physics. 2021 Nov;111(3S):e447.
       Full Text
    • Qiao EM, Qian AS, Nalawade V, Kotha NV, Voora RS, Murphy JD. Predicting Unplanned Hospitalization Among Patients Receiving Definitive Radiation. International Journal of Radiation Oncology, Biology, Physics. 2021 Nov;111(3S):e117.
       Full Text
    • Qiao EM, Voora RS, Nalawade V, Kotha NV, Qian AS, Nelson TJ, et al. Evaluating Clinical Trends and Benefits of Low-Dose CT in Lung Cancer Patients. International Journal of Radiation Oncology, Biology, Physics. 2021 Nov;111(3S):e449–50.
       Full Text
    • Seible DM, Kundu S, Azuara A, Cherry DR, Arias S, Nalawade VV, et al. The Influence of Patient-Provider Language Concordance in Cancer Care: Results of the Hispanic Outcomes by Language Approach (HOLA) Randomized Trial. International Journal of Radiation Oncology, Biology, Physics. 2021 Nov;111(4):856–64.
       Full Text
    • Qiao EM, Voora RS, Nalawade V, Kotha NV, Qian AS, Nelson TJ, et al. Evaluating the clinical trends and benefits of low-dose computed tomography in lung cancer patients. Cancer Medicine. 2021 Oct;10(20):7289–97.
       Full Text
    • Zhou B, Joudeh A, Desai MJ, Kwan B, Nalawade V, Whitcomb BW, et al. Trends in Infertility Care Among Commercially Insured US Women During the COVID-19 Pandemic. Jama Network Open. 2021 Oct;4(10):e2128520.
       Full Text
    • Kumar A, Cherry DR, Courtney PT, Nalawade V, Kotha N, Riviere PJ, et al. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans. European Urology Open Science. 2021 Aug;30:1–10.
       Full Text
    • Vitzthum LK, Nalawade V, Riviere P, Sumner W, Nelson T, Mell LK, et al. Racial, Ethnic, and Socioeconomic Discrepancies in Opioid Prescriptions Among Older Patients With Cancer. Jco Oncology Practice. 2021 Jun;17(6):e703–13.
       Full Text
    • Lee TC, Qiao EM, Qian AS, Nalawade V, Voora RS, Kotha NV, et al. Predictors of inpatient admission for pediatric cancer patients visiting the emergency department. Journal of Clinical Oncology. 2021 May 20;39(15_suppl):e22019–e22019.
       Full Text
    • Marar M, Nalawade V, Panjwani N, Riviere P, Furnish T, Lin LA, et al. Impact of the VA opioid safety initiative on pain management for cancer patients. Journal of Clinical Oncology. 2021 May 20;39(15_suppl):102–102.
       Full Text
    • Qian A, Qiao E, Nalawade V, Kotha NV, Voora RS, Murphy JD. Impact of cancer on the risk of unplanned 30-day readmissions. Journal of Clinical Oncology. 2021 May 20;39(15_suppl):6581–6581.
       Full Text
    • Qian AS, Qiao EM, Nalawade V, Voora RS, Kotha NV, Dameff C, et al. Impact of cancer on emergency department outcomes. Journal of Clinical Oncology. 2021 May 20;39(15_suppl):e18618–e18618.
       Full Text
    • Qiao E, Kotha NV, Nalawade V, Qian A, Voora RS, Nelson TJ, et al. Association of increased intensity of prostate-specific antigen screening in younger African American men with improved prostate cancer outcomes. Journal of Clinical Oncology. 2021 May 20;39(15_suppl):5004–5004.
       Full Text
    • Qiao E, Qian A, Nalawade V, Lee TC, Kotha NV, Voora RS, et al. Evaluating a high-dimensional machine-learning model to predict hospital mortality among elderly cancer patients. Journal of Clinical Oncology. 2021 May 20;39(15_suppl):1512–1512.
       Full Text
    • Nelson TJ, Javier-DesLoges J, Deka R, Courtney PT, Nalawade V, Mell L, et al. Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance. Jama Network Open. 2021 May 3;4(5):e219452.
       Full Text
    • Kotha NV, Cherry DR, Bryant AK, Nalawade V, Stewart TF, Rose BS. Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff point. Clinical and Translational Radiation Oncology. 2021 May;28:133–40.
       Full Text
    • Riviere P, Vitzthum LK, Nalawade V, Deka R, Furnish T, Mell LK, et al. Validation of an oncology-specific opioid risk calculator in cancer survivors. Cancer. 2021 May;127(9):1529–35.
       Full Text
    • Chen Q, Cherry DR, Nalawade V, Qiao EM, Kumar A, Lowy AM, et al. Clinical Data Prediction Model to Identify Patients With Early-Stage Pancreatic Cancer. Jco Clinical Cancer Informatics. 2021 Mar;5:279–87.
       Full Text
    • Kotha NV, Kumar A, Qiao EM, Cherry DR, Nalawade V, Kader AK, et al. Impact of equal access healthcare on race disparities in bladder cancer. Journal of Clinical Oncology. 2021 Feb 20;39(6_suppl):399–399.
       Full Text
    • Deka R, Parsons JK, Simpson DR, Riviere P, Nalawade V, Vitzthum LK, et al. African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance. Prostate Cancer and Prostatic Diseases. 2020 Dec;23(4):581–8.
       Full Text
    • Deka R, Courtney PT, Parsons JK, Nelson TJ, Nalawade V, Luterstein E, et al. Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance. Jama. 2020 Nov;324(17):1747–54.
       Full Text
    • Salans MA, Riviere P, Vitzthum L, Nalawade V, Murphy JD. Trends in short-term, long-term, and high-risk opioid use among older cancer patients. Journal of Clinical Oncology. 2020 Oct 10;38(29_suppl):187–187.
       Full Text
    • Kumar A, Riviere P, Luterstein E, Nalawade V, Vitzthum L, Sarkar RR, et al. Associations among statins, preventive care, and prostate cancer mortality. Prostate Cancer and Prostatic Diseases. 2020 Sep;23(3):475–85.
       Full Text
    • Kumar A, Guss ZD, Courtney PT, Nalawade V, Sheridan P, Sarkar RR, et al. Evaluation of the Use of Cancer Registry Data for Comparative Effectiveness Research. Jama Network Open. 2020 Jul;3(7):e2011985.
       Full Text
    • Vitzthum LK, Riviere P, Sheridan P, Nalawade V, Deka R, Furnish T, et al. Predicting Persistent Opioid Use, Abuse, and Toxicity Among Cancer Survivors. Journal of the National Cancer Institute. 2020 Jul;112(7):720–7.
       Full Text
    • Riviere P, Kumar A, Luterstein E, Vitzthum LK, Nalawade V, Sarkar RR, et al. Tobacco smoking and death from prostate cancer in US veterans. Prostate Cancer and Prostatic Diseases. 2020 Jun;23(2):252–9.
       Full Text
    • Martin EJ, Bruggeman AR, Nalawade VV, Sarkar RR, Qiao EM, Rose BS, et al. Palliative Radiotherapy Versus Esophageal Stent Placement in the Management of Patients With Metastatic Esophageal Cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 2020 May;18(5):569–74.
       Full Text
    • Vitzthum LK, Park H, Zakeri K, Heide ES, Nalawade V, Mundt AJ, et al. Risk of Pelvic Fracture With Radiation Therapy in Older Patients. International Journal of Radiation Oncology, Biology, Physics. 2020 Mar;106(3):485–92.
       Full Text
    • Deka R, Simpson DR, Panizzon MS, Hauger RL, Riviere P, Nalawade V, et al. Stroke and thromboembolic events in men with prostate cancer treated with definitive radiation therapy with or without androgen deprivation therapy. Prostate Cancer and Prostatic Diseases. 2019 Dec;22(4):600–8.
       Full Text
    • Kumar A, Nalawade V, Riviere P, Sarkar RR, Parsons JK, Murphy JD, et al. Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults. Jama Network Open. 2019 Oct 2;2(10):e1913612.
       Full Text
    • Martin EJ, Nalawade VV, Murphy JD, Jones JA. Incorporating palliative radiotherapy education into hospice and palliative medicine fellowship training: a feasibility study. Annals of Palliative Medicine. 2019 Sep;8(4):436–41.
       Full Text
    • Moran RJ, Waalen J, Murphy J, Nalawade V, Schiaffino M. Pneumococcal Vaccination Utilization Among Hispanic Long-Term Colorectal Cancer Survivors: Cross-Sectional Assessment of Claims. Jmir Public Health and Surveillance. 2019 May 13;5(2):e12603.
       Full Text
    • Deka R, Rose BS, Bryant AK, Sarkar RR, Nalawade V, McKay R, et al. Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy. Cancer. 2019 Apr;125(7):1070–80.
       Full Text
    • Riviere P, Tokeshi C, Hou J, Nalawade V, Sarkar R, Paravati AJ, et al. Claims-Based Approach to Predict Cause-Specific Survival in Men With Prostate Cancer. Jco Clinical Cancer Informatics. 2019 Mar;3:1–7.
       Full Text
    • Deka R, Simpson DR, Bryant AK, Nalawade V, McKay R, Murphy JD, et al. Association of Androgen Deprivation Therapy With Dementia in Men With Prostate Cancer Who Receive Definitive Radiation Therapy. Jama Oncology. 2018 Nov;4(11):1616–7.
       Full Text

  • Conference Papers

    • Lee TC, Qiao EM, Qian AS, Nalawade V, Voora RS, Kotha NV, et al. Predictors of inpatient admission for pediatric cancer patients visiting the emergency department. In: Journal of Clinical Oncology. 2021.
       Link to Item

  • Preprints

    • Kumar A, Guss ZD, Courtney PT, Nalawade V, Sheridan P, Sarkar RR, et al. Validity of using cancer registry data for comparative effectiveness research. Cold Spring Harbor Laboratory.
       Full Text
    • Moran RJ, Waalen J, Murphy J, Nalawade V, Schiaffino M. Pneumococcal Vaccination Utilization Among Hispanic Long-Term Colorectal Cancer Survivors: Cross-Sectional Assessment of Claims (Preprint). JMIR Publications Inc.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.